Lungcarcinoma, lung cancer
Conditions
Interventions
 
The intervention consists of two components: a preoperative and a postoperative 
phase. Preoperatively, patients receive additional information through a 
virtual patient journey, where all steps from the outpatient clinic to 
discharge are explained and shown via a virtual tour. Postoperatively, patients 
use the LUVRE application, designed to serve as distraction therapy to 
alleviate pain. Within the software, patients can select different calming 
environments in which they wish to immerse themselves.
Preoperatively, patients will experience the virtual patient journey at the 
outpatient clinic. The postoperative intervention schedule begins on Day 0 
after surgery, with a single 20-minute session. From Day 1 post-surgery, the 
intervention group will receive distraction therapy twice daily for 20 minutes 
per session, continuing for 5 days after the operation. This is provided in 
addition to the conventional pain management for lung cancer patients 
undergoing VATS.
The placebo group receives no intervention, only the conventional pain 
management for lung cancer patients undergoing VATS. 
Sponsors
Leids Universitair Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: • Patient*s age >=18 years • Planned for oncological lung resection and visiting outpatient clinic
Exclusion criteria
Exclusion criteria: • Hearing and/or visual impairments • Psychiatric impairments • Complaints of vomiting and nausea • History of epilepsy • Vestibulocochlear disorders including Meniere*s disease, Benign Paroxysmal Positional Vertigo • Claustrophobia • Facial wounds and skin defects at site of application • Patients placed in clinical isolation • (Re)admission to the intensive care unit • If planned surgery is not executed
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Amsterdam Preoperative Anxiety and Information Scale (APAIS) - Numeric Rating Scale (NRS) to assess pain - Quality of Recovery-15 (QoR-15) questionnaire - State-Trait Anxiety Inventory-6 (STAI-6) questionnaire - Assessment of analgesic use in morphine milligram equivalents (MME), NSAID's and Paracetamol | — |
Secondary
| Measure | Time frame |
|---|---|
| * The subjective experience of patients undergoing VR distraction therapy * The heart rate variability of a patient undergoing VR distraction therapy as a biometric proxy for pain relief & anxiety reduction. * Length of Stay of patients in both groups | — |
Countries
Netherlands
Contacts
Public ContactL.N.A. Coopmans
Leids Universitair Medisch Centrum
Outcome results
None listed